It was reported that GLY treatment effectively reduced HMGB1 expression at both mRNA and protein level in infection or non-infection corneal injury and thus to improve corneal repair (Ekanayaka et al., 2016; Zhou et al., 2020). The gene discussed is HMGB1; the disease is infection.